Compositions for oral use with hmg-coa reductase enzyme inhibiting activity

EP4709402A1Pending Publication Date: 2026-03-18DIFASS INT
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-05-08
Publication Date
2026-03-18

Smart Images

  • Figure IMGF000008_0001
    Figure IMGF000008_0001
  • Figure IMGF000008_0002
    Figure IMGF000008_0002
  • Figure IMGF000009_0001
    Figure IMGF000009_0001
Patent Text Reader

Abstract

Disclosed are compositions comprising an Olea europaea extract and a Scutellaria baicalensis extract for use in the treatment of dyslipidaemia as inhibitors of the HMG-CoA reductase enzyme.
Need to check novelty before this filing date? Find Prior Art